FDA Sets New Standards for Psychedelic Clinical Trials
As interest in psychedelic medicines continues to grow, new regulatory expectations are shaping how future therapies will reach patients. Recent interventional psychiatry research highlights…
Read More
Latest Articles
Does Cannabis or Alcohol Affect TMS Outcomes?
July 25, 2026
How TMS Harnesses Neuroplasticity
July 22, 2026
Get the Mental Health Breakthroughs
No One Else Is Talking About
Every week, we deliver the latest news, research, and real-world updates from the frontlines of interventional psychiatry.
Join the IPN Newsletter
Reach out for guest article or sponsorship opportunities
Interested in collaborating with us?
Share your details, and let’s explore how we can work together to create meaningful experiences for our audience.